Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Invo Bioscience Inc    IVOB

INVO BIOSCIENCE INC

(IVOB)
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

INVO BIOSCIENCE, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 05:22pm EDT

Item 2.02. Results of Operations and Financial Condition

On August 14, 2019, INVO Bioscience, Inc. (the "Company") issued a press release regarding its financial results for the quarterly period ended June 30, 2019. A copy of the press release, dated August 14, 2019, is attached hereto as Exhibit 99.1.

The information in this Item 2.02 of Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 of Form 8-K and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits



Exhibit No.   Description

99.1            Press Release INVO Bioscience, Inc. dated August 14, 2019

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INVO BIOSCIENCE INC
08/14INVO BIOSCIENCE, INC. : Results of Operations and Financial Condition, Financial..
AQ
08/14INVO BIOSCIENCE : Management's Discussion and Analysis of Financial Condition an..
AQ
05/15INVO BIOSCIENCE : Management's Discussion and Analysis of Financial Condition an..
AQ
04/16INVO BIOSCIENCE : Management s Discussion and Analysis of Financial Condition an..
AQ
02/04INVO BIOSCIENCE : Appoints Michael J. Campbell as COO & VP of Business Developme..
PR
01/17INVO BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Other Events..
AQ
01/16SUN PHARMACEUTICAL INDUSTRIES : Ferring Pharmaceuticals adds two products to its..
AQ
01/15INVO BIOSCIENCE : Closes Exclusive U.S. Licensing Agreement with Ferring Pharmac..
AQ
2018INVO BIOSCIENCE : Management's Discussion and Analysis of Financial Condition an..
AQ
2018INVO BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Other Events..
AQ
More news